Can seriousness of respiratory failure be predicted by the values of clinical score in patients with acute severe asthma? Source: Eur Respir J 2001; 18: Suppl. 33, 73s Year: 2001
Baseline symptom scores and future risk of severe exacerbation: The SPARK study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Predicting persistence of childhood wheeze using a symptom based severity score Source: Annual Congress 2008 - Early life risk factors for childhood asthma: evidence from birth cohort studies II Year: 2008
Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV1 predict treatment failure during hospitalisation due to COPD exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 525s Year: 2007
Early occurrence of any COPD exacerbation predicts further higher risk of moderate/severe exacerbations regardless of recording tool: the FLAME study Source: International Congress 2017 – Management of COPD Year: 2017
Patients with fluctuant peak expiratory flow value in the absent category are insensitive to dyspnea and are at risk for severe asthma exacerbation Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases Year: 2011
Predicting frequent exacerbations in a severe asthma centre. Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020
Impact of stable state symptoms on the future burden of COPD exacerbations Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018
Early detection of asthma exacerbations by using action points in self-management plans Source: Eur Respir J 2013; 41: 53-59 Year: 2013
Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT Source: International Congress 2014 – Markers Year: 2014
The derivation of a new index of severity for COPD patients, the DOSE index: MRC d yspnea scale, airflow o bstruction, s moking status and e xacerbations Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation Year: 2007
Does the duration of symptoms pre admission influence the clinical course of the exacerbation in COPD? Source: Eur Respir J 2004; 24: Suppl. 48, 15s Year: 2004
Fluctuations in lung function vs. asthma control, exacerbations and severity: An alternate look at phenotyping asthma Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring Year: 2010
Impact of onset time in patients with asthma Source: Eur Respir J 2003; 22: Suppl. 45, 480s Year: 2003
Change in breathlessness and symptom scores during hospitalisation with exacerbations of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 511s Year: 2004
Relationship between asthma symptom score and attack frequency Source: Eur Respir J 2005; 26: Suppl. 49, 277s Year: 2005
Is sustained control of severe asthma possible? A composite score to assess 1-year of asthma control Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013
Does higher DECAF score increase length of hospital stay in acute exacerbation of COPD? Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016
Do DECAF scores for acute exacerbation of COPD correlate with hospital anxiety and depression scale? Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019
Value of measuring SGRQ at stable phase of COPD to predict the timing and deterioration associated with next exacerbation: the MOSAIC study Source: Eur Respir J 2004; 24: Suppl. 48, 240s Year: 2004